Inflammasome induction in Rasmussen’s encephalitis: cortical and associated white matter pathogenesis

Springer Science and Business Media LLC - Tập 10 Số 1 - Trang 1-10 - 2013
Ramaswamy, Vijay1,2, Walsh, John G3, Sinclair, D Barry1, Johnson, Edward4, Tang-Wai, Richard1, Wheatley, B Matt5, Branton, William3, Maingat, Ferdinand3, Snyder, Thomas6, Gross, Donald W3, Power, Christopher6,7
1Division of Pediatric Neurology, University of Alberta, Edmonton, Canada
2Arthur and Sonia Labatt Brain Tumor Research Centre, Hospital for Sick Children, Toronto, Canada
3Department of Medicine (Neurology), University of Alberta, Edmonton, Canada
4Department of Laboratory Medicine and Pathology (Neuropathology), University of Alberta, Edmonton, Canada
5Department of Surgery/Neurosurgery, University of Alberta, Edmonton, Canada
6Department of Psychiatry, University of Alberta, Edmonton, Canada
7Department of Medicine, University of Alberta, 6-11 Heritage Medical Research Centre, Edmonton, Canada

Tóm tắt

Rasmussen’s encephalitis (RE) is an inflammatory encephalopathy of unknown cause defined by seizures with progressive neurological disabilities. Herein, the pathogenesis of RE was investigated focusing on inflammasome activation in the brain. Patients with RE at the University of Alberta, Edmonton, AB, Canada, were identified and analyzed by neuroimaging, neuropsychological, molecular, and pathological tools. Primary human microglia, astrocytes, and neurons were examined using RT-PCR, enzyme-linked immunosorbent assay (ELISA), and western blotting. Four patients with RE were identified at the University of Alberta. Magnetic resonance imaging (MRI) disclosed increased signal intensities in cerebral white matter adjacent to cortical lesions of RE patients, accompanied by a decline in neurocognitive processing speed (P <0.05). CD3ϵ, HLA-DRA, and TNFα together with several inflammasome-associated genes (IL-1β, IL-18, NLRP1, NLRP3, and CASP1) showed increased transcript levels in RE brains compared to non-RE controls (n = 6; P <0.05). Cultured human microglia displayed expression of inflammasome-associated genes and responded to inflammasome activators by releasing IL-1β, which was inhibited by the caspase inhibitor, zVAD-fmk. Major histocompatibility complex (MHC) class II, IL-1β, caspase-1, and alanine/serine/cysteine (ASC) immunoreactivity were increased in RE brain tissues, especially in white matter myeloid cells, in conjunction with mononuclear cell infiltration and gliosis. Neuroinflammation in RE brains was present in both white matter and adjacent cortex with associated induction of inflammasome components, which was correlated with neuroimaging and neuropsychological deficits. Inflammasome activation likely contributes to the disease process underlying RE and offers a mechanistic target for future therapeutic interventions.

Tài liệu tham khảo

citation_journal_title=Epilepsy Res; citation_title=Early onset Rasmussen’s syndrome: a malignant, often bilateral form of the disorder; citation_author=F Andermann, K Farrell; citation_volume=70; citation_issue=Suppl 1; citation_publication_date=2006; citation_pages=S259-S262; citation_doi=10.1016/j.eplepsyres.2006.02.011; citation_id=CR1 citation_journal_title=Neurology; citation_title=Focal seizures due to chronic localized encephalitis; citation_author=T Rasmussen, J Olszewski, D Lloydsmith; citation_volume=8; citation_publication_date=1958; citation_pages=435-445; citation_doi=10.1212/WNL.8.6.435; citation_id=CR2 citation_journal_title=Pediatr Neurol; citation_title=Rasmussen’s syndrome: progressive autoimmune multi-focal encephalopathy; citation_author=JM Freeman; citation_volume=32; citation_publication_date=2005; citation_pages=295-299; citation_doi=10.1016/j.pediatrneurol.2004.12.002; citation_id=CR3 citation_journal_title=Brain; citation_title=Pathogenesis, diagnosis and treatment of Rasmussen encephalitis: A European consensus statement; citation_author=CG Bien; citation_volume=128; citation_publication_date=2005; citation_pages=454-471; citation_doi=10.1093/brain/awh415; citation_id=CR4 citation_journal_title=Curr Treat Options Neurol; citation_title=Rasmussen’s Encephalitis; citation_author=D Counce, N Limdi, R Kuzniecky; citation_volume=3; citation_publication_date=2001; citation_pages=555-563; citation_doi=10.1007/s11940-001-0018-5; citation_id=CR5 citation_journal_title=Epileptic Disord; citation_title=Rasmussen’s encephalitis; citation_author=Y Hart; citation_volume=6; citation_publication_date=2004; citation_pages=133-144; citation_id=CR6 citation_journal_title=Pediatr Neurol; citation_title=Epilepsiapartialis continua: acute disseminated encephalomyelitis or Rasmussen’s encephalitis?; citation_author=V Ramaswamy, DB Sinclair, BM Wheatley, L Richer, T Snyder; citation_volume=32; citation_publication_date=2005; citation_pages=341-345; citation_doi=10.1016/j.pediatrneurol.2005.01.001; citation_id=CR7 citation_journal_title=Ann Neurol; citation_title=Destruction of neurons by cytotoxic T cells: A new pathogenic mechanism in rasmussen’s encephalitis; citation_author=CG Bien, J Bauer, TL Deckwerth, H Wiendl, M Deckert, OD Wiestler, J Schramm, CE Elger, H Lassmann; citation_volume=51; citation_publication_date=2002; citation_pages=311-318; citation_doi=10.1002/ana.10100; citation_id=CR8 citation_journal_title=Lancet; citation_title=Cytomegalovirus and Rasmussen’s encephalitis; citation_author=C Power, SD Poland, WT Blume, JP Girvin, GP Rice; citation_volume=336; citation_publication_date=1990; citation_pages=1282-1284; citation_doi=10.1016/0140-6736(90)92965-K; citation_id=CR9 citation_journal_title=Epilepsia; citation_title=The pathology of Rasmussen syndrome: stages of cortical involvement and neuropathological studies in 45 hemispherectomies; citation_author=CA Pardo, EP Vining, L Guo, RL Skolasky, BS Carson, JM Freeman; citation_volume=45; citation_publication_date=2004; citation_pages=516-526; citation_doi=10.1111/j.0013-9580.2004.33103.x; citation_id=CR10 citation_journal_title=Trends Immunol; citation_title=Toll-like receptor (TLR) and inflammasome actions in the central nervous system; citation_author=R Hanamsagar, ML Hanke, T Kielian; citation_volume=33; citation_publication_date=2012; citation_pages=333-342; citation_doi=10.1016/j.it.2012.03.001; citation_id=CR11 citation_journal_title=Nat Immunol; citation_title=Regulation of inflammasome signaling; citation_author=VA Rathinam, SK Vanaja, KA Fitzgerald; citation_volume=13; citation_publication_date=2012; citation_pages=333-332; citation_doi=10.1038/ni.2237; citation_id=CR12 citation_journal_title=J Immunol; citation_title=NLRP3 plays a critical role in the development of experimental autoimmune encephalomyelitis by mediating Th1 and Th17 responses; citation_author=D Gris, Z Ye, HA Iocca, H Wen, RR Craven, P Gris, M Huang, M Schneider, SD Miller, JP Ting; citation_volume=185; citation_publication_date=2010; citation_pages=974-981; citation_doi=10.4049/jimmunol.0904145; citation_id=CR13 citation_journal_title=J Immunol; citation_title=The NLRP3 inflammasome contributes to brain injury in pneumococcal meningitis and is activated through ATP-dependent lysosomalcathepsin B release; citation_author=T Hoegen, N Tremel, M Klein, B Angele, H Wagner, C Kirschning, HW Pfister, A Fontana, S Hammerschmidt, U Koedel; citation_volume=187; citation_publication_date=2011; citation_pages=5440-5451; citation_doi=10.4049/jimmunol.1100790; citation_id=CR14 citation_journal_title=Nature; citation_title=NLRP3 is activated in Alzheimer’s disease and contributes to pathology in APP/PS1 mice; citation_author=MT Heneka, MP Kummer, A Stutz, A Delekate, S Schwartz, A Vieira-Saecker, A Griep, D Axt, A Remus, TC Tzeng, E Gelpi, A Halle, M Korte, E Latz, DT Golenbock; citation_volume=493; citation_publication_date=2013; citation_pages=674-678; citation_doi=10.1038/nature11729; citation_id=CR15 citation_journal_title=Pediatr Neurol; citation_title=Pediatric epilepsy surgery at the University of Alberta: 1988–2000; citation_author=DB Sinclair, KE Aronyk, TJ Snyder, BM Wheatley, JD McKean, R Bhargava, M Hoskinson, C Hao, WF Colmers, M Berg, W Mak; citation_volume=29; citation_publication_date=2003; citation_pages=302-311; citation_doi=10.1016/S0887-8994(03)00307-2; citation_id=CR16 citation_journal_title=J Immunol; citation_title=Early life exposure to lipopolysaccharide suppresses experimental autoimmune encephalomyelitis by promoting tolerogenic dendritic cells and regulatory T cells; citation_author=KK Ellestad, S Tsutsui, F Noorbakhsh, KG Warren, VW Yong, QJ Pittman, C Power; citation_volume=183; citation_publication_date=2009; citation_pages=298-309; citation_doi=10.4049/jimmunol.0803576; citation_id=CR17 citation_journal_title=Ann Neurol; citation_title=Cerebral white matter changes in acquired immunodeficiency syndrome dementia: alterations of the blood–brain barrier; citation_author=C Power, PA Kong, TO Crawford, S Wesselingh, JD Glass, JC McArthur, BD Trapp; citation_volume=34; citation_publication_date=1993; citation_pages=339-350; citation_doi=10.1002/ana.410340307; citation_id=CR18 citation_journal_title=FASEB J; citation_title=CXCR3 activation by lentivirus infection suppresses neuronal autophagy: neuroprotective effects of antiretroviral therapy; citation_author=Y Zhu, D Vergote, C Pardo, F Noorbakhsh, JC McArthur, MD Hollenberg, CM Overall, C Power; citation_volume=23; citation_publication_date=2009; citation_pages=2928-2941; citation_doi=10.1096/fj.08-128819; citation_id=CR19 citation_journal_title=Retrovirology; citation_title=Interactions between human immunodeficiency virus (HIV)-1 Vpr expression and innate immunity influence neurovirulence; citation_author=H Na, S Acharjee, G Jones, P Vivithanaporn, F Noorbakhsh, N McFarlane, F Maingat, K Ballanyi, CA Pardo, EA Cohen, C Power; citation_volume=8; citation_publication_date=2011; citation_pages=44; citation_doi=10.1186/1742-4690-8-44; citation_id=CR20 citation_journal_title=FASEB J; citation_title=Differential type 1 interferon-regulated gene expression in the brain during AIDS: interactions with viral diversity and neurovirulence; citation_author=MJ Polyak, P Vivithanaporn, FG Maingat, JG Walsh, W Branton, EA Cohen, R Meeker, C Power; citation_volume=27; citation_publication_date=2013; citation_pages=2829-2844; citation_doi=10.1096/fj.13-227868; citation_id=CR21 citation_journal_title=Am J Clin Pathol; citation_title=Rasmussen encephalitis: a clinicopathologic and immunohistochemical study of seven patients; citation_author=RA Prayson, JL Frater; citation_volume=117; citation_publication_date=2002; citation_pages=776-782; citation_doi=10.1309/AD8R-560C-4V11-C5E2; citation_id=CR22 citation_journal_title=Brain; citation_title=CD8+ T-cell clones dominate brain infiltrates in Rasmussen encephalitis and persist in the periphery; citation_author=N Schwab, CG Bien, A Waschbisch, A Becker, GH Vince, K Dornmair, H Wiendl; citation_volume=132; citation_publication_date=2009; citation_pages=1236-1246; citation_doi=10.1093/brain/awp003; citation_id=CR23 citation_journal_title=Ann Neurol; citation_title=Astrocytes are a specific immunological target in Rasmussen’s encephalitis; citation_author=J Bauer, CE Elger, VH Hans, J Schramm, H Urbach, H Lassmann, CG Bien; citation_volume=62; citation_publication_date=2007; citation_pages=67-80; citation_doi=10.1002/ana.21148; citation_id=CR24 citation_journal_title=Brain; citation_title=Imaging of axonal damage in vivo in Rasmussen’s syndrome; citation_author=F Cendes, F Andermann, K Silver, DL Arnold; citation_volume=118; citation_issue=Pt 3; citation_publication_date=1995; citation_pages=753-758; citation_doi=10.1093/brain/118.3.753; citation_id=CR25 citation_journal_title=Int J Radiat Oncol Biol Phys; citation_title=White matter fractional anisotropy correlates with speed of processing and motor speed in young childhood cancer survivors; citation_author=EJ Aukema, MW Caan, N Oudhuis, CB Majoie, FM Vos, L Reneman, BF Last, MA Grootenhuis, AY Schouten-van Meeteren; citation_volume=74; citation_publication_date=2009; citation_pages=837-843; citation_doi=10.1016/j.ijrobp.2008.08.060; citation_id=CR26 citation_journal_title=J Virol; citation_title=Lentiviral neuropathogenesis: comparative neuroinvasion, neurotropism, neurovirulence, and host neurosusceptibility; citation_author=MK Patrick, JB Johnston, C Power; citation_volume=76; citation_publication_date=2002; citation_pages=7923-7931; citation_doi=10.1128/JVI.76.16.7923-7931.2002; citation_id=CR27 citation_journal_title=J Clin Invest; citation_title=MFGE8 inhibits inflammasome-induced IL-1beta production and limits postischemic cerebral injury; citation_author=N Deroide, X Li, D Lerouet, E Van Vré, L Baker, J Harrison, M Poittevin, L Masters, L Nih, I Margaill, Y Iwakura, B Ryffel, M Pocard, A Tedgui, N Kubis, Z Mallat; citation_volume=123; citation_publication_date=2013; citation_pages=1176-1181; citation_doi=10.1172/JCI65167; citation_id=CR28 citation_journal_title=PLoS One; citation_title=The cytokine release inhibitory drug CRID3 targets ASC oligomerisation in the NLRP3 and AIM2 inflammasomes; citation_author=RC Coll, LA O'Neill; citation_volume=6; citation_publication_date=2011; citation_pages=e29539; citation_doi=10.1371/journal.pone.0029539; citation_id=CR29